Soligenix, Inc. (SNGX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Soligenix, Inc. (SNGX) is down 72.1% since the beginning of the year. At $0 per share, SNGX is trading 94.0% below its 52-week high of $6. Investors who bought $1,000 worth of SNGX shares 5 years ago would now be looking at an investment worth $2.

Soligenix, Inc. (SNGX) has returned -72.10% so far this year and -86.35% over the past 12 months. Over the last ten years, SNGX has returned -56.49% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.

Based on dividend-adjusted daily data since Mar 8, 2012, SNGX's average daily return is +0.06%, while the average monthly return is +0.01%. At this rate, an investment would double in approximately 577.7 years.

Historically, 37% of months were positive and 63% were negative. The best month was Jan 2013 with a return of +198.3%, while the worst month was Apr 2026 at -70.8%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 10 months.

On a daily basis, SNGX closed higher 42% of trading days. The best single day was Jul 9, 2024 with a return of +271.0%, while the worst single day was Apr 28, 2026 at -70.3%.

Soligenix, Inc. has an annualized alpha of 8.20%, beta of 0.63, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 08, 2012.

• This stock participated in 218.66% of S&P 500 Index downside but only -34.70% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.63 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SNGX ranks 16 for risk / return — above 16% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Soligenix, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Soligenix, Inc. was 100.00%, occurring on May 11, 2026. The portfolio has not yet recovered.

The current Soligenix, Inc. drawdown is 99.99%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Soligenix, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Soligenix, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.